Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

First case of Lucio's phenomenon in a lepromatous leprosy patient following COVID-19 viral vector vaccine.

Soares-Neto R, da Piedade G, Pereira P, et al. EXCLI journal. 2023;
Download PDF
Publication

Percepção do estigma em pacientes de hanseníase: implicações na gestão de saúde em Colinas, Maranhão, Brasil.

Batista G. M, da Cunha S. M, Santos Aliança A. S. Dos. Peer Review. 2023;
Download PDF
Publication

Association of PTX3 gene polymorphisms and PTX3 plasma levels with leprosy susceptibility.

Moraes A, da Luz R, Fernandes A, et al. BMC infectious diseases. 2023; 23 (1) : 1-7.
Download PDF
Publication

Whole mitogenome sequencing uncovers a relation between mitochondrial heteroplasmy and leprosy severity.

de Souza F, da Silva M, de Araújo G, et al. Human genomics. 2023; 17 (1) : 1-15.
Download PDF
Publication

Infância isolada: política pública para a profilaxia da lepra no Maranhão (1930-1950)

Dutra RDMM, Giglio CMB. FapUNIFESP (SciELO). Educar em Revista. 2023;
Download PDF
Publication

Primary health care essential and derivative attributes in children and adolescents with leprosy

Sousa GSD, Cardoso JMS, Cortela DDCB, et al. FapUNIFESP (SciELO). Texto & Contexto - Enfermagem. 2023;
Download PDF
Publication

O WhatsApp como possível ferramenta para favorecer a adesão ao tratamento da tuberculose e hanseníase

Beatriz Godinho Louvain A, Miguel Soares Neto F, Araújo Galvão de Souza C, et al. Faculdade de Medicina de Campos. Anais da Semana Científica da Faculdade de Medicina de Campos. 2023;
Download PDF
Publication

Aspectos clínicos e epidemiológicos da hanseníase em região de saúde hiperendêmica da Amazônia Legal no período de 2008 – 2018

Novais DG, Barbosa SM, Mariano WDS, et al. South Florida Publishing LLC. CONTRIBUCIONES A LAS CIENCIAS SOCIALES. 2023; 16 (11) : 25903-25923.
Download PDF
Publication

Perfil epidemiológico dos casos de Hanseníase no estado do Piauí-Brasil

Sampaio APF, Costa RMPG. South Florida Publishing LLC. CONTRIBUCIONES A LAS CIENCIAS SOCIALES. 2023; 16 (10) : 24333-24343.
Download PDF
Publication

Bartonella henselae as a putative trigger for chronic type 2 leprosy reactions.

Santos L, Drummond M, Goulart I, et al. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2023; 27 (6) : 1-7.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 42
  • Next page ››
Subscribe to Brazil

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD